Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0024 | 0.0666 | 1 |
Brugia malayi | RNA binding protein | 0.0064 | 0.3205 | 1 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0019 | 0.0384 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0064 | 0.3205 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0018 | 0.0282 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0019 | 0.0384 | 0.5 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0024 | 0.0666 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0019 | 0.0384 | 0.5 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0018 | 0.0282 | 0.5 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0019 | 0.0384 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0666 | 0.1313 |
Loa Loa (eye worm) | RNA binding protein | 0.0064 | 0.3205 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.0384 | 0.2642 |
Giardia lamblia | DINP protein human, muc B family | 0.0019 | 0.0384 | 0.5 |
Onchocerca volvulus | 0.0024 | 0.0666 | 0.5 | |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.0666 | 0.1001 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0024 | 0.0666 | 1 |
Echinococcus multilocularis | geminin | 0.0171 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0024 | 0.0666 | 1 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0024 | 0.0666 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0019 | 0.0384 | 0.3665 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.0666 | 0.1001 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0024 | 0.0666 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3205 | 0.2934 |
Schistosoma mansoni | hypothetical protein | 0.0171 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.0384 | 0.2642 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0384 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0018 | 0.0282 | 0.139 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0064 | 0.3205 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0666 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0024 | 0.0666 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0666 | 0.1313 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3205 | 0.2934 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0024 | 0.0666 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3205 | 0.2934 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0666 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0024 | 0.0666 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0384 | 0.0347 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0019 | 0.0384 | 0.0347 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3205 | 0.2934 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 0.5 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0019 | 0.0384 | 0.3665 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0666 | 0.1313 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0384 | 1 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0024 | 0.0666 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0064 | 0.3205 | 0.2934 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0024 | 0.0666 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0024 | 0.0666 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0064 | 0.3205 | 1 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0024 | 0.0666 | 1 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0024 | 0.0666 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0024 | 0.0666 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0384 | 1 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0018 | 0.0282 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0171 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3205 | 0.2934 |
Trypanosoma brucei | unspecified product | 0.0019 | 0.0384 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.0666 | 0.1001 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0666 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0064 | 0.3205 | 0.2934 |
Brugia malayi | TAR-binding protein | 0.0064 | 0.3205 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.